A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005839:Gentamicins / Q000627:therapeutic use; D006470:Hemorrhage / Q000401:mortality; D006801:Humans; D017053:Infection Control; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010357:Patient Isolators; D011446:Prospective Studies; D011552:Pseudomonas Infections / Q000517:prevention & control; D012075:Remission, Spontaneous; D012141:Respiratory Tract Infections / Q000517:prevention & control; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009761:Nystatin; D014640:Vancomycin